Bucci, 1st named to the AngioDynamics board in 2007, was named chairman later that year. He stepped down in March.
AngioDynamics said that Donnelly, 52, has been a board member since 2004. In addition to his role at Concert Medical, Donnelly is president & CEO of HydroCision, according to a press release.
"Howard’s medical device expertise and leadership since joining the board in 2004 are invaluable, and I look forward to continue working with him and the rest of the board to ensure we execute our business plan," AngioDynamics president & CEO Joseph DeVivo said in prepared remarks.
"I am delighted the other board members have entrusted me to become AngioDynamics’ next chairman," Donnelly added. "We have made significant progress commercializing innovative and disruptive products, such as the AngioVac Cannula and Circuit, our BioFlo platform and the Acculis microwave system, driving four quarters of improved sales results and positioning us for continued success."
AngioDynamics put some black ink in the ledger during its fiscal 3rd quarter, handily topping Wall Street’s earnings forecast. The Latham, N.Y.-based medical device company reported profits of $5.1 million, or 14¢ per share, on sales of $88.2 million for the 3 months ended Feb 28. That compares with losses of- $992,000, or -3¢ per share, on sales of $81.6 million for the 3rd quarter of fiscal 2013, for sales growth of 8.1%.